Skip to Main Content

Paper Details

Palbociclib in Patients With Pancreatic and Biliary Cancer With <i>CDKN2A</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.
JCO Precis Oncol
49
2019
Author NameAffiliation
Elizabeth Garrett-MayerAmerican Society of Clinical Oncology
Kathleen J Yost
  • 1 - 2

Datasets

Release 1.2